130 related articles for article (PubMed ID: 27380874)
1. Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer.
Aleskandarany MA; Green AR; Ashankyty I; Elmouna A; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Jul; 158(2):287-95. PubMed ID: 27380874
[TBL] [Abstract][Full Text] [Related]
2. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
[TBL] [Abstract][Full Text] [Related]
3. Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value.
Joshi S; Watkins J; Gazinska P; Brown JP; Gillett CE; Grigoriadis A; Pinder SE
BMC Cancer; 2015 Jul; 15():546. PubMed ID: 26205655
[TBL] [Abstract][Full Text] [Related]
4. Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections.
Muftah AA; Aleskandarany MA; Al-Kaabi MM; Sonbul SN; Diez-Rodriguez M; Nolan CC; Caldas C; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2017 Jul; 164(2):341-348. PubMed ID: 28478613
[TBL] [Abstract][Full Text] [Related]
5. High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy.
Zurrida S; Bagnardi V; Curigliano G; Mastropasqua MG; Orecchia R; Disalvatore D; Greco M; Cataliotti L; D'Aiuto G; Talakhadze N; Goldhirsch A; Viale G
Eur J Cancer; 2013 Oct; 49(15):3083-92. PubMed ID: 23777741
[TBL] [Abstract][Full Text] [Related]
6. Digital image analysis of Ki67 in hot spots is superior to both manual Ki67 and mitotic counts in breast cancer.
Stålhammar G; Robertson S; Wedlund L; Lippert M; Rantalainen M; Bergh J; Hartman J
Histopathology; 2018 May; 72(6):974-989. PubMed ID: 29220095
[TBL] [Abstract][Full Text] [Related]
7. Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma.
Laurinavicius A; Plancoulaine B; Rasmusson A; Besusparis J; Augulis R; Meskauskas R; Herlin P; Laurinaviciene A; Abdelhadi Muftah AA; Miligy I; Aleskandarany M; Rakha EA; Green AR; Ellis IO
Virchows Arch; 2016 Apr; 468(4):493-502. PubMed ID: 26818835
[TBL] [Abstract][Full Text] [Related]
8. High Ki67/BCL2 index is associated with worse outcome in early stage breast cancer.
Min KW; Kim DH; Do SI; Pyo JS; Chae SW; Sohn JH; Kim K; Lee HJ; Kim DH; Oh S; Choi SH; Park YL; Park CH; Kwon MJ; Moon KM
Postgrad Med J; 2016 Dec; 92(1094):707-714. PubMed ID: 27222586
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral heterogeneity of Ki67 expression in early breast cancers exceeds variability between individual tumours.
Focke CM; Decker T; van Diest PJ
Histopathology; 2016 Nov; 69(5):849-861. PubMed ID: 27270560
[TBL] [Abstract][Full Text] [Related]
10. An interobserver reproducibility analysis of Ki67 visual assessment in breast cancer.
Shui R; Yu B; Bi R; Yang F; Yang W
PLoS One; 2015; 10(5):e0125131. PubMed ID: 25932921
[TBL] [Abstract][Full Text] [Related]
11. Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas.
Protzel C; Knoedel J; Zimmermann U; Woenckhaus C; Poetsch M; Giebel J
Histol Histopathol; 2007 Nov; 22(11):1197-204. PubMed ID: 17647192
[TBL] [Abstract][Full Text] [Related]
12. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
Falck AK; Fernö M; Bendahl PO; Rydén L
World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical results for HER2 and Ki67 in breast cancer touch-smear cell specimens are reliable.
Morimoto M; Bando Y; Nakagawa M; Takechi H; Yoshida T; Honda J; Tadokoro Y; Moriya T; Sasa M; Tangoku A
Breast Cancer; 2016 Jul; 23(4):577-82. PubMed ID: 25808597
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.
Zhong F; Bi R; Yu B; Yang F; Yang W; Shui R
PLoS One; 2016; 11(2):e0150505. PubMed ID: 26928407
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical assessment of Ki67 with antibodies SP6 and MIB1 in primary breast cancer: a comparison of prognostic value and reproducibility.
Ekholm M; Beglerbegovic S; Grabau D; Lövgren K; Malmström P; Hartman L; Fernö M
Histopathology; 2014 Aug; 65(2):252-60. PubMed ID: 24527721
[TBL] [Abstract][Full Text] [Related]
16. MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups.
Aleskandarany MA; Rakha EA; Macmillan RD; Powe DG; Ellis IO; Green AR
Breast Cancer Res Treat; 2011 Jun; 127(3):591-9. PubMed ID: 20623333
[TBL] [Abstract][Full Text] [Related]
17. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
18. Ki-67 expression in axillary lymph node metastases in breast cancer is prognostically significant.
Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
Hum Pathol; 2013 Jan; 44(1):39-46. PubMed ID: 22939959
[TBL] [Abstract][Full Text] [Related]
19. Expression, assessment and significance of Ki67 expression in breast cancer: an update.
Lashen AG; Toss MS; Ghannam SF; Makhlouf S; Green A; Mongan NP; Rakha E
J Clin Pathol; 2023 Jun; 76(6):357-364. PubMed ID: 36813558
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the expression of prognostic biomarkers between primary tumor and axillary lymph node metastases in breast cancer.
Zhao S; Xu L; Liu W; Lv C; Zhang K; Gao H; Wang J; Ma R
Int J Clin Exp Pathol; 2015; 8(5):5744-8. PubMed ID: 26191291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]